Enterprise Value
-3.588M
Cash
4.734M
Avg Qtr Burn
-1.866M
Short % of Float
12.14%
Insider Ownership
2.47%
Institutional Own.
1.75%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DMT310 Details Acne vulgaris, Acne | Phase 3 Data readout | |
DMT310 Details Psoriasis | Phase 2 Update | |
DMT310 Details Papulopustular rosacea | Failed Discontinued |